SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-073272
Filing Date
2010-03-31
Accepted
2010-03-31 15:29:53
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1046959
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1920
3 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) dex311.htm EX-31.1 6622
4 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) dex312.htm EX-31.2 6745
5 CERTIFICATION OF CEO & CFO PURSUANT TO 13A-14(B) OR 15D-14(B) dex321.htm EX-32.1 5641
6 GRAPHIC g66661g06u33.jpg GRAPHIC 45682
  Complete submission text file 0001193125-10-073272.txt   1132549
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 10718752
SIC: 2834 Pharmaceutical Preparations